Your browser doesn't support javascript.
loading
: 20 | 50 | 100
1 - 5 de 5
4.
Pediatr Dermatol ; 37(6): 1128-1130, 2020 Nov.
Article En | MEDLINE | ID: mdl-32770747

We report the case of a 5-year-old girl with congenital right-sided facial hemihypertrophy and right hemi-macroglossia with lingual mucosal neuromas. The segmental presentation of findings suggested the diagnosis of congenital infiltrating lipomatosis of the face (CILF), which belongs within the PIK3CA-related overgrowth spectrum (PROS). This was confirmed by genetic analysis showing a mosaic mutation in PIK3CA H1047R. CILF/PROS should be considered in the differential diagnosis of mucosal neuromas.


Lipomatosis , Neuroma , Child, Preschool , Class I Phosphatidylinositol 3-Kinases/genetics , Face , Facial Asymmetry , Female , Humans , Mutation
5.
Eur J Hum Genet ; 24(7): 992-1000, 2016 07.
Article En | MEDLINE | ID: mdl-26626311

Heterozygous COL2A1 variants cause a wide spectrum of skeletal dysplasia termed type II collagenopathies. We assessed the impact of this gene in our French series. A decision tree was applied to select 136 probands (71 Stickler cases, 21 Spondyloepiphyseal dysplasia congenita cases, 11 Kniest dysplasia cases, and 34 other dysplasia cases) before molecular diagnosis by Sanger sequencing. We identified 66 different variants among the 71 positive patients. Among those patients, 18 belonged to multiplex families and 53 were sporadic. Most variants (38/44, 86%) were located in the triple helical domain of the collagen chain and glycine substitutions were mainly observed in severe phenotypes, whereas arginine to cysteine changes were more often encountered in moderate phenotypes. This series of skeletal dysplasia is one of the largest reported so far, adding 44 novel variants (15%) to published data. We have confirmed that about half of our Stickler patients (46%) carried a COL2A1 variant, and that the molecular spectrum was different across the phenotypes. To further address the question of genotype-phenotype correlation, we plan to screen our patients for other candidate genes using a targeted next-generation sequencing approach.


Amino Acid Substitution , Arthritis/genetics , Collagen Diseases/genetics , Collagen Type II/genetics , Connective Tissue Diseases/genetics , Hearing Loss, Sensorineural/genetics , Osteochondrodysplasias/genetics , Phenotype , Retinal Detachment/genetics , Arthritis/pathology , Collagen Diseases/pathology , Collagen Type II/chemistry , Connective Tissue Diseases/pathology , Female , Hearing Loss, Sensorineural/pathology , Humans , Male , Osteochondrodysplasias/pathology , Pedigree , Protein Domains , Retinal Detachment/pathology
...